An oBservational retrospective Analysis of treatment patternS and Effectiveness of standard of CAre for Multiple Myeloma Patients Exposed to Lenalidomide and a Proteasome Inhibitor: BasecaMMp Study | Synapse
March 3, 2026Open Access
An oBservational retrospective Analysis of treatment patternS and Effectiveness of standard of CAre for Multiple Myeloma Patients Exposed to Lenalidomide and a Proteasome Inhibitor: BasecaMMp Study
Key Points
Poor clinical outcomes were observed for multiple myeloma patients receiving standard care, emphasizing the need for improved treatment strategies.
Only a small number of effective therapies have been identified, including lenalidomide and proteasome inhibitors for this patient population.
Observational retrospective analysis of treatment patterns shows inconsistencies in care for multiple myeloma patients exposed to certain medications.
Highlighting the lack of a clear standard of care for multiple myeloma calls for new approaches to increase treatment effectiveness.
Abstract
These findings highlight the lack of a clear standard of care, poor clinical outcomes, and the need for more effective therapies and treatment strategies for this population.